Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced a collaboration agreement with Navignostics AG for development of clinical research applications and service offerings using the Hyperion XTi™ Imaging System.
Related news for (LAB)
- Today’s Top Performers: MoBot’s Market Review 08/22/25 09:00 AM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/22/25 08:00 AM
- Today’s Top Performers: MoBot’s Market Review 06/23/25 09:00 AM
- Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
- 24/7 Market News Snapshot 23 June, 2025 – Standard BioTools Inc. Common Stock (NASDAQ:LAB)